Your browser doesn't support javascript.
loading
A Durable Response With the Combination of Nivolumab and Cabozantinib in a Patient With Metastatic Paraganglioma: A Case Report and Review of the Current Literature.
Economides, Minas P; Shah, Amishi Y; Jimenez, Camilo; Habra, Mouhammed A; Desai, Monica; Campbell, Matthew T.
Afiliación
  • Economides MP; Department of Internal Medicine, The University of Texas School of Health Sciences at Houston, Houston, TX, United States.
  • Shah AY; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Jimenez C; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Habra MA; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Desai M; Department of Oncology/Hematology, Houston Methodist Cancer Center, Houston, TX, United States.
  • Campbell MT; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Front Endocrinol (Lausanne) ; 11: 594264, 2020.
Article en En | MEDLINE | ID: mdl-33329398
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paraganglioma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Prognostic_studies Límite: Adult / Humans / Male Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paraganglioma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Prognostic_studies Límite: Adult / Humans / Male Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza